Sopan Pharmaceuticals (SOPL) share price is Rs. 627.10, down 3.42% on 2026-11-02. Open Rs. 645.00. High Rs. 645.80. Low Rs. 625.10. Volume 18,326.
Sopan Pharmaceuticals Limited is a NEPSE-listed company (SOPL), Manufacturing And Processing sector. Revenue: Rs. 50.05 Crore. Net profit: Rs. 21.78 Crore. Net worth: Rs. 161.6 Crore.
Sopan Pharmaceuticals Limited (SOPL) has 1,71,60,000 shares outstanding.
| Market Cap | Rs. 1,076.10 Crore |
|---|---|
| P/E Ratio | 49.41 |
| EPS | Rs. 12.69 |
| Book Value | Rs. 94.17 |
| Dividend Yield | 0.00% |
| Face Value | Rs. 100.00 |
| 52 Week High | Rs. 1,217.00 |
| 52 Week Low | Rs. 276.50 |
What Sopan Pharmaceuticals Limited's own accounts show in its favour, graded against the rest of its sector.
What the same accounts show against it. Both lists are computed from the filed figures, not opinion, and are not advice.
For the financial year 2081/82 Sopan Pharmaceuticals Limited reported net profit of Rs. 21.78 crore, revenue from operations of Rs. 50.05 crore and net worth of Rs. 161.6 crore. Net profit in 2080/81 was a loss of Rs. 8.27 crore. Net profit turned from a loss to a profit on the year. Revenue from operations grew 229.90% on the year.
In the financial year 2081/82, Sopan Pharmaceuticals Limited reported revenue from operations of Rs. 50.05 crore, gross profit of Rs. 38.04 crore, operating profit of Rs. 29.82 crore, profit before tax of Rs. 24.13 crore and net profit for the year of Rs. 21.78 crore.
Reported under gross profit: cost of sales of Rs. 12.02 crore. Reported under operating profit: other income of Rs. 1.97 crore, selling and distribution expenses of Rs. 4.07 crore, administrative expenses of Rs. 4.27 crore, employee benefit expenses of Rs. 0 crore, depreciation and amortisation of Rs. 1.85 crore, allowance for expected credit loss of Rs. 0 crore and other operating expenses of Rs. 0 crore. Reported under profit before tax: finance costs of Rs. 5.69 crore and gain on investments through fair value of Rs. 0 crore. Reported under net profit for the year: current tax of Rs. 0 crore, deferred tax of Rs. 2.35 crore and prior period tax adjustment of Rs. 0 crore.
In the financial year 2080/81, Sopan Pharmaceuticals Limited reported revenue from operations of Rs. 15.17 crore, gross profit of Rs. 5.23 crore, operating profit of Rs. 1.81 crore, profit before tax of Rs. 10.33 crore and net profit for the year of Rs. 8.27 crore.
Reported under gross profit: cost of sales of Rs. 9.94 crore. Reported under operating profit: other income of Rs. 3.01 crore, selling and distribution expenses of Rs. 4.36 crore, administrative expenses of Rs. 4.06 crore, employee benefit expenses of Rs. 0 crore, depreciation and amortisation of Rs. 1.62 crore, allowance for expected credit loss of Rs. 0 crore and other operating expenses of Rs. 0 crore. Reported under profit before tax: finance costs of Rs. 8.53 crore and gain on investments through fair value of Rs. 0 crore. Reported under net profit for the year: current tax of Rs. 0 crore, deferred tax of Rs. 2.07 crore and prior period tax adjustment of Rs. 0 crore.
In the financial year 2079/80, Sopan Pharmaceuticals Limited reported revenue from operations of Rs. 14.03 crore, gross profit of Rs. 2.68 crore, operating profit of Rs. 8.79 crore, profit before tax of Rs. 18.26 crore and net profit for the year of Rs. 28.65 crore.
Reported under gross profit: cost of sales of Rs. 11.34 crore. Reported under operating profit: other income of Rs. 0.01 crore, selling and distribution expenses of Rs. 5.3 crore, administrative expenses of Rs. 4.44 crore, employee benefit expenses of Rs. 0 crore, depreciation and amortisation of Rs. 1.74 crore, allowance for expected credit loss of Rs. 0 crore and other operating expenses of Rs. 0 crore. Reported under profit before tax: finance costs of Rs. 9.47 crore and gain on investments through fair value of Rs. 0 crore. Reported under net profit for the year: current tax of Rs. 0 crore, deferred tax of Rs. 10.39 crore and prior period tax adjustment of Rs. 0 crore.
In the financial year 2081/82, Sopan Pharmaceuticals Limited reported total non-current assets of Rs. 162.5 crore, total current assets of Rs. 69.95 crore, total equity of Rs. 161.6 crore, total non-current liabilities of Rs. 52.37 crore and total current liabilities of Rs. 18.48 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 147.5 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 0 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 15 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 10.34 crore, trade receivables of Rs. 56.27 crore, cash and cash equivalents of Rs. 1.03 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 2.32 crore, income tax assets (net) of Rs. 0 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 0 crore and other current assets of Rs. 0 crore. Reported under total equity: share capital of Rs. 128.7 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 32.9 crore, retained earnings of Rs. 0 crore, other equity of Rs. 0 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 43.84 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 8.03 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0.5 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 10.73 crore, trade payables of Rs. 4.07 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore, other current liabilities of Rs. 3.68 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
In the financial year 2080/81, Sopan Pharmaceuticals Limited reported total non-current assets of Rs. 167.89 crore, total current assets of Rs. 29.1 crore, total equity of Rs. 109.09 crore, total non-current liabilities of Rs. 63.43 crore and total current liabilities of Rs. 24.46 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 167.88 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 0 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 0 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 6.58 crore, trade receivables of Rs. 19.24 crore, cash and cash equivalents of Rs. 1.51 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 1.76 crore, income tax assets (net) of Rs. 0 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 0 crore and other current assets of Rs. 0 crore. Reported under total equity: share capital of Rs. 99 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 10.09 crore, retained earnings of Rs. 0 crore, other equity of Rs. 0 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 54.99 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 5.68 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 2.76 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 14.6 crore, trade payables of Rs. 2.73 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore, other current liabilities of Rs. 7.13 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
In the financial year 2079/80, Sopan Pharmaceuticals Limited reported total non-current assets of Rs. 167.23 crore, total current assets of Rs. 16.6 crore, total equity of Rs. 87.98 crore, total non-current liabilities of Rs. 76.53 crore and total current liabilities of Rs. 19.33 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 167.23 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 0.01 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 0 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 5.06 crore, trade receivables of Rs. 9.59 crore, cash and cash equivalents of Rs. 0.29 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 1.67 crore, income tax assets (net) of Rs. 0 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 0 crore and other current assets of Rs. 0 crore. Reported under total equity: share capital of Rs. 68 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 18.35 crore, retained earnings of Rs. 0 crore, other equity of Rs. 1.63 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 64.88 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 7.75 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 3.9 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 11.16 crore, trade payables of Rs. 2.14 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore, other current liabilities of Rs. 6.03 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
In the financial year 2081/82, Sopan Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 1.51 crore, net cash from operating activities of Rs. 15.33 crore, net cash from investing activities of Rs. 4.19 crore, net cash from financing activities of Rs. 10.66 crore, net change in cash of Rs. 0.48 crore and closing cash & cash equivalents of Rs. 1.03 crore.
Reported under net cash from operating activities: profit before tax of Rs. 24.13 crore, adjustment for depreciation and amortisation of Rs. 1.85 crore, adjustment for finance costs of Rs. 5.69 crore, changes in working capital of Rs. 45.71 crore, income tax paid of Rs. 0 crore and other operating adjustments of Rs. 1.29 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 2.3 crore, proceeds from sale of property, plant and equipment of Rs. 21.49 crore, purchase of investments of Rs. 15 crore, interest received of Rs. 0 crore, dividend received of Rs. 0 crore and other investing activities of Rs. 0 crore. Reported under net cash from financing activities: proceeds from borrowings of Rs. 0 crore, repayment of borrowings of Rs. 15.02 crore, payment of lease liabilities of Rs. 0 crore, dividends paid of Rs. 0 crore, interest paid of Rs. 5.06 crore and other financing activities of Rs. 30.74 crore.
In the financial year 2080/81, Sopan Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 0.29 crore, net cash from operating activities of Rs. 10.9 crore, net cash from investing activities of Rs. 2.27 crore, net cash from financing activities of Rs. 14.4 crore, net change in cash of Rs. 1.22 crore and closing cash & cash equivalents of Rs. 1.51 crore.
Reported under net cash from operating activities: profit before tax of Rs. 10.33 crore, adjustment for depreciation and amortisation of Rs. 1.62 crore, adjustment for finance costs of Rs. 8.53 crore, changes in working capital of Rs. 10.71 crore, income tax paid of Rs. 0 crore and other operating adjustments of Rs. 0 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 2.27 crore, proceeds from sale of property, plant and equipment of Rs. 0 crore, purchase of investments of Rs. 0 crore, interest received of Rs. 0 crore, dividend received of Rs. 0 crore and other investing activities of Rs. 0 crore. Reported under net cash from financing activities: proceeds from borrowings of Rs. 0 crore, repayment of borrowings of Rs. 6.45 crore, payment of lease liabilities of Rs. 0 crore, dividends paid of Rs. 0 crore, interest paid of Rs. 8.53 crore and other financing activities of Rs. 29.37 crore.
In the financial year 2079/80, Sopan Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 0.21 crore, net cash from operating activities of Rs. 3.7 crore, net cash from investing activities of Rs. 1.49 crore, net cash from financing activities of Rs. 2.28 crore, net change in cash of Rs. 0.08 crore and closing cash & cash equivalents of Rs. 0.29 crore.
Reported under net cash from operating activities: profit before tax of Rs. 18.26 crore, adjustment for depreciation and amortisation of Rs. 1.74 crore, adjustment for finance costs of Rs. 9.47 crore, changes in working capital of Rs. 3.35 crore, income tax paid of Rs. 0 crore and other operating adjustments of Rs. 0 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 1.01 crore, proceeds from sale of property, plant and equipment of Rs. 2.5 crore, purchase of investments of Rs. 0 crore, interest received of Rs. 0 crore, dividend received of Rs. 0 crore and other investing activities of Rs. 0 crore. Reported under net cash from financing activities: proceeds from borrowings of Rs. 0 crore, repayment of borrowings of Rs. 0.75 crore, payment of lease liabilities of Rs. 0 crore, dividends paid of Rs. 0 crore, interest paid of Rs. 9.47 crore and other financing activities of Rs. 12.5 crore.
Values in Rs. Crore unless stated otherwise.
| Particulars | 2081/82 | 2080/81 | 2079/80 |
|---|---|---|---|
| Revenue from Operations | 50.1 | 15.2 | 14.0 |
| Gross Profit | 38.0 | 5.2 | 2.7 |
| Cost of Sales | -12.0 | -9.9 | -11.3 |
| Operating Profit | 29.8 | -1.8 | -8.8 |
| Other Income | 2.0 | 3.0 | 0.01 |
| Selling and Distribution Expenses | -4.1 | -4.4 | -5.3 |
| Administrative Expenses | -4.3 | -4.1 | -4.4 |
| Employee Benefit Expenses | 0.00 | 0.00 | 0.00 |
| Depreciation and Amortisation | -1.8 | -1.6 | -1.7 |
| Allowance for Expected Credit Loss | 0.00 | 0.00 | 0.00 |
| Other Operating Expenses | 0.00 | 0.00 | 0.00 |
| Profit Before Tax | 24.1 | -10.3 | -18.3 |
| Finance Costs | -5.7 | -8.5 | -9.5 |
| Gain on Investments through Fair Value | 0.00 | 0.00 | 0.00 |
| Net Profit for the Year | 21.8 | -8.3 | -28.7 |
| Current Tax | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.4 | 2.1 | -10.4 |
| Prior Period Tax Adjustment | 0.00 | 0.00 | 0.00 |
Values in Rs. Crore unless stated otherwise.
| Particulars | 2081/82 | 2080/81 | 2079/80 |
|---|---|---|---|
| Total Non-Current Assets | 163 | 168 | 167 |
| Property, Plant and Equipment | 147 | 168 | 167 |
| Capital Work-in-Progress | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.00 | 0.00 | 0.01 |
| Right-of-Use Assets | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 0.00 | 0.00 | 0.00 |
| Investment in Quoted Shares | 0.00 | 0.00 | 0.00 |
| Investment in Subsidiaries | 15.0 | 0.00 | 0.00 |
| Other Financial Assets | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 70.0 | 29.1 | 16.6 |
| Inventories | 10.3 | 6.6 | 5.1 |
| Trade Receivables | 56.3 | 19.2 | 9.6 |
| Cash and Cash Equivalents | 1.0 | 1.5 | 0.29 |
| Bank Balance (other than Cash and Cash Equivalents) | 0.00 | 0.00 | 0.00 |
| Advances | 2.3 | 1.8 | 1.7 |
| Income Tax Assets (Net) | 0.00 | 0.00 | 0.00 |
| Investments in Fixed Deposit | 0.00 | 0.00 | 0.00 |
| Prepayments | 0.00 | 0.00 | 0.00 |
| Other Financial Assets | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 |
| Total Equity | 162 | 109 | 88.0 |
| Share Capital | 129 | 99.0 | 68.0 |
| Share Premium Reserve | 0.00 | 0.00 | 0.00 |
| Reserve and Surplus | 32.9 | 10.1 | 18.4 |
| Retained Earnings | 0.00 | 0.00 | 0.00 |
| Other Equity | 0.00 | 0.00 | 1.6 |
| Non-Controlling Interest | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 52.4 | 63.4 | 76.5 |
| Long Term Borrowings | 43.8 | 55.0 | 64.9 |
| Lease Liabilities | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities (Net) | 8.0 | 5.7 | 7.7 |
| Retirement Benefit Obligation | 0.00 | 0.00 | 0.00 |
| Other Financial Liabilities | 0.50 | 2.8 | 3.9 |
| Provisions | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 18.5 | 24.5 | 19.3 |
| Short Term Borrowings | 10.7 | 14.6 | 11.2 |
| Trade Payables | 4.1 | 2.7 | 2.1 |
| Lease Liabilities | 0.00 | 0.00 | 0.00 |
| Retirement Benefit Obligation | 0.00 | 0.00 | 0.00 |
| Other Financial Liabilities | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 3.7 | 7.1 | 6.0 |
| Provisions | 0.00 | 0.00 | 0.00 |
| Income Tax Liabilities (Net) | 0.00 | 0.00 | 0.00 |
Values in Rs. Crore unless stated otherwise.
| Particulars | 2081/82 | 2080/81 | 2079/80 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 1.5 | 0.29 | 0.21 |
| Net Cash from Operating Activities | -15.3 | -10.9 | -3.7 |
| Profit Before Tax | 24.1 | -10.3 | -18.3 |
| Adjustment for Depreciation and Amortisation | 1.8 | 1.6 | 1.7 |
| Adjustment for Finance Costs | 5.7 | 8.5 | 9.5 |
| Changes in Working Capital | -45.7 | -10.7 | 3.3 |
| Income Tax Paid | 0.00 | 0.00 | 0.00 |
| Other Operating Adjustments | -1.3 | 0.00 | 0.00 |
| Net Cash from Investing Activities | 4.2 | -2.3 | 1.5 |
| Purchase of Property, Plant and Equipment | -2.3 | -2.3 | -1.0 |
| Proceeds from Sale of Property, Plant and Equipment | 21.5 | 0.00 | 2.5 |
| Purchase of Investments | -15.0 | 0.00 | 0.00 |
| Interest Received | 0.00 | 0.00 | 0.00 |
| Dividend Received | 0.00 | 0.00 | 0.00 |
| Other Investing Activities | 0.00 | 0.00 | 0.00 |
| Net Cash from Financing Activities | 10.7 | 14.4 | 2.3 |
| Proceeds from Borrowings | 0.00 | 0.00 | 0.00 |
| Repayment of Borrowings | -15.0 | -6.4 | -0.75 |
| Payment of Lease Liabilities | 0.00 | 0.00 | 0.00 |
| Dividends Paid | 0.00 | 0.00 | 0.00 |
| Interest Paid | -5.1 | -8.5 | -9.5 |
| Other Financing Activities | 30.7 | 29.4 | 12.5 |
| Net Change in Cash | -0.48 | 1.2 | 0.08 |
| Closing Cash & Cash Equivalents | 1.0 | 1.5 | 0.29 |
Over the last 15 trading sessions SOPL closed between Rs. 606.00 and Rs. 673.00, finishing at Rs. 627.10 on 2026-11-02 against Rs. 633.00 on 2026-10-05.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2026-11-02 | 645.00 | 645.80 | 625.10 | 627.10 | 18,326 |
| 2026-10-30 | 673.00 | 689.00 | 649.00 | 649.30 | 23,579 |
| 2026-10-29 | 619.00 | 676.70 | 619.00 | 673.00 | 76,828 |
| 2026-10-28 | 606.00 | 619.10 | 601.20 | 619.00 | 17,700 |
| 2026-10-27 | 606.00 | 614.90 | 605.10 | 606.30 | 11,580 |
| 2026-10-26 | 615.00 | 618.00 | 605.00 | 612.00 | 10,568 |
| 2026-10-16 | 600.00 | 615.00 | 600.00 | 615.00 | 15,208 |
| 2026-10-14 | 600.00 | 611.00 | 600.00 | 610.00 | 18,365 |
| 2026-10-13 | 606.00 | 614.80 | 603.00 | 607.00 | 10,527 |
| 2026-10-12 | 615.00 | 620.00 | 605.00 | 606.00 | 30,412 |
| 2026-10-09 | 620.00 | 630.00 | 612.00 | 615.00 | 19,367 |
| 2026-10-08 | 601.00 | 632.00 | 601.00 | 623.00 | 17,472 |
| 2026-10-07 | 635.00 | 640.00 | 630.00 | 632.00 | 18,012 |
| 2026-10-06 | 630.00 | 645.00 | 630.00 | 640.00 | 13,065 |
| 2026-10-05 | 650.00 | 650.10 | 630.00 | 633.00 | 38,322 |
At Rs. 627.10 on 2026-11-02, SOPL is up 2.47% over 1 week, down 4.05% over 1 month and down 22.39% over 3 months. Each return compares that close with the last close on or before the same date in the earlier period.
| Period | Return | From price (Rs.) | From date |
|---|---|---|---|
| 1 week | +2.47% | 612.00 | 2026-10-26 |
| 1 month | -4.05% | 653.60 | 2026-10-02 |
| 3 months | -22.39% | 808.00 | 2026-08-04 |
SOPL traded 535 times on 2026-11-02, moving 18,326 shares for Rs. 1.16 crore of turnover. Trades went through between Rs. 625.10 and Rs. 645.80.
Largest buyers by volume: broker 42, Sani Securities Company Limited on 2,210 shares across 28 trades, broker 58, Naasa Securities Co. Ltd. on 1,192 shares across 56 trades, broker 48, Trishakti Securities Public Limited on 1,122 shares across 26 trades, broker 72, Hatemalo Financial Services Private Limited on 1,000 shares across 2 trades, broker 22, Siprabi Securities Pvt. Limited on 746 shares across 21 trades, broker 45, Imperial Securities Co. Limited on 700 shares across 15 trades, broker 53, Investment Management Nepal Pvt. Ltd. on 680 shares across 10 trades, broker 37, Swarnalaxmi Securities Pvt.Limited on 650 shares across 12 trades, broker 57, Arya Tara Investment And Securities Pvt. Ltd. on 620 shares across 29 trades and broker 49, Online Securities Limited on 612 shares across 11 trades.
Largest sellers by volume: broker 58, Naasa Securities Co. Ltd. on 2,166 shares across 118 trades, broker 41, Linch Stock Market Limited on 2,050 shares across 31 trades, broker 62, Capital Max Securities Limited on 1,900 shares across 15 trades, broker 53, Investment Management Nepal Pvt. Ltd. on 1,540 shares across 24 trades, broker 6, Agrawal Securities Pvt. Limited on 1,150 shares across 11 trades, broker 49, Online Securities Limited on 1,105 shares across 48 trades, broker 17, ABC Securities Pvt. Limited on 858 shares across 15 trades, broker 34, Vision Securities Pvt.Limited on 740 shares across 17 trades, broker 42, Sani Securities Company Limited on 730 shares across 30 trades and broker 60, Nagarik Stock Dealer Company Ltd. on 701 shares across 8 trades.
Annual and special general meetings Sopan Pharmaceuticals Limited has called. A dividend is declared by the board and approved at the AGM.
3 years of annual statements for SOPL, with charts and peer comparison, are free on NepView.
New to these statements? How to read a profit and loss statement, How to read a balance sheet, How to read a cash flow statement, How to read quarterly results.
All manufacturing and processing companies on NEPSE